Abstract
Study objectives
The aim was to investigate the association between ZNF184 and symptoms of Parkinson’s disease (PD) in southern Chinese.
Methods
A total of 241 PD patients were recruited in this study. All patients were evaluated by Sniffin’ Sticks 16 (SS-16), Hamilton anxiety rating scale and Hamilton depression rating scale, 39-item Parkinson’s disease Questionnaire (PDQ-39) and MDS-Unified PD Rating Scale (MDS-UPDRS). Symptoms were also recorded.
Results
There was association of rapid eye movement sleep behavior disorder (RBD) under additive, dominant and overdominant model (p 0.039, additive; p 0.028, dominant; p 0.044, overdominant). We also found the association of excessive daytime sleepiness under the dominant model, the association of urgent urination or urinary incontinence under the recessive model and the association of sensitive to hot under the overdominant model (excessive daytime sleepiness: p 0.032, dominant; p 0.038, dominant; urgent urination or urgent incontinence: p 0.027, recessive; sensitive to hot: p, 0.027, overdominant).
Conclusions
ZNF184 rs9468199 was associated with the presence of RBD, excessive daytime sleepiness, urgent urination or urgent incontinence and sensitive to hot.
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- CI:
-
confidence interval
- MDS:
-
movement disorders society
- MMSE:
-
Mini-Mental State Examination
- MoCA:
-
Montreal Cognitive Assessment
- NMSS:
-
non-motor symptoms scale
- OR:
-
odds ratio
- PD:
-
Parkinson’s disease
- PDQ-39:
-
39-item Parkinson’s disease Questionnaire
- RBD:
-
rapid eye movement sleep behavior disorder
- RLS:
-
restless legs syndrome
- SCOPA-AUT:
-
scales for Outcomes in Parkinson’s disease-autonomic questionnaire
- SS-16:
-
Sniffin’ Sticks 16
- UPDRS:
-
unified Parkinson’s disease rating scale
References
Kalia LV, Lang AE (2015) Parkinson’s disease. Lancet 386(9996):896–912. https://doi.org/10.1016/s0140-6736(14)61393-3
Bene R, Antic S, Budisic M, Lisak M, Trkanjec Z, Demarin V, Podobnik-Sarkanji S (2009) Parkinson’s disease. Acta Clin Croat 48(3):377–380
Blanca Ramirez M, Madero-Perez J, Rivero-Rios P, Martinez-Salvador M, Lara Ordonez AJ, Fernandez B, Fdez E, Hilfiker S (2017) LRRK2 and Parkinson’s disease: from lack of structure to gain of function. Curr Protein Pept Sci 18(7):677–686. https://doi.org/10.2174/1389203717666160311121748
Siddiqui IJ, Pervaiz N, Abbasi AA (2016) The Parkinson disease gene SNCA: evolutionary and structural insights with pathological implication. Sci Rep 6:24475. https://doi.org/10.1038/srep24475
Koros C, Simitsi A, Stefanis L (2017) Genetics of Parkinson’s disease: genotype-phenotype correlations. Int Rev Neurobiol 132:197–231. https://doi.org/10.1016/bs.irn.2017.01.009
Gaig C, Vilas D, Infante J, Sierra M, Garcia-Gorostiaga I, Buongiorno M, Ezquerra M, Marti MJ, Valldeoriola F, Aguilar M, Calopa M, Hernandez-Vara J, Tolosa E (2014) Nonmotor symptoms in LRRK2 G2019S associated Parkinson’s disease. PLoS One 9(10):e108982. https://doi.org/10.1371/journal.pone.0108982
Chang D, Nalls MA, Hallgrimsdottir IB, Hunkapiller J, van der Brug M, Cai F, Kerchner GA, Ayalon G, Bingol B, Sheng M, Hinds D, Behrens TW, Singleton AB, Bhangale TR, Graham RR (2017) A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci. Nat Genet 49(10):1511–1516. https://doi.org/10.1038/ng.3955
Li G, Cui S, Du J, Liu J, Zhang P, Fu Y, He Y, Zhou H, Ma J, Chen S (2018) Association of GALC, ZNF184, IL1R2 and ELOVL7 with Parkinson’s disease in Southern Chinese. Front Aging Neurosci 10:402. https://doi.org/10.3389/fnagi.2018.00402
Goldwurm S, Menzies ML, Banyer JL, Powell LW, Jazwinska EC (1997) Identification of a novel Krueppel-related zinc finger gene (ZNF184) mapping to 6p21.3. Genomics 40(3):486–489. https://doi.org/10.1006/geno.1996.4583
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601. https://doi.org/10.1002/mds.26424
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2008) Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170. https://doi.org/10.1002/mds.22340
Chen W, Chen S, Kang WY, Li B, Xu ZM, Xiao Q, Liu J, Wang Y, Wang G, Chen SD (2012) Application of odor identification test in Parkinson’s disease in China: a matched case-control study. J Neurol Sci 316(1–2):47–50. https://doi.org/10.1016/j.jns.2012.01.033
Shen SS, Shen Y, Xiong KP, Chen J, Mao CJ, Huang JY, Li J, Han F, Liu CF (2014) Validation study of REM sleep behavior disorder questionnaire-Hong Kong (RBDQ-HK) in East China. Sleep Med 15(8):952–958. https://doi.org/10.1016/j.sleep.2014.03.020
Mandaviya PR, Joehanes R, Aissi D, Kuhnel B, Marioni RE, Truong V, Stolk L, Beekman M, Bonder MJ, Franke L, Gieger C, Huan T, Ikram MA, Kunze S, Liang L, Lindemans J, Liu C, McRae AF, Mendelson MM, Muller-Nurasyid M, Peters A, Slagboom PE, Starr JM, Tregouet DA, Uitterlinden AG, van Greevenbroek MMJ, van Heemst D, van Iterson M, Wells PS, Yao C, Deary IJ, Gagnon F, Heijmans BT, Levy D, Morange PE, Waldenberger M, Heil SG, van Meurs JBJ (2017) Genetically defined elevated homocysteine levels do not result in widespread changes of DNA methylation in leukocytes. PLoS One 12(10):e0182472. https://doi.org/10.1371/journal.pone.0182472
Garcia S, Cano-Martinez LJ, Coral-Vazquez RM, Coronel-Perez A, Gomez-Diaz B, Toledo-Lozano CG, Gallegos-Arreola MP, Davila-Maldonado L, Jimenez-Hernandez DA, Alcaraz-Estrada SL, Lopez-Hernandez LB (2017) Analysis of the rs13306560 functional variant in the promoter region of the MTHFR gene in sporadic Parkinson’s disease. Neuro Endocrinol Lett 38(4):257–260
Liao Q, Li NN, Mao XY, Chang XL, Zhao DM, Zhang JH, Yu WJ, Tan EK, Peng R (2014) MTHFR C677T variant reduces risk of sporadic Parkinson’s disease in ethnic Chinese. Acta Neurol Scand 130(1):e30–e34. https://doi.org/10.1111/ane.12245
Liu L, Zhang L, Guo L, Yu Q, Li H, Teng J, Xie A (2018) MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson’s disease: a meta-analysis of 19 studies. Neurosci Lett 662:339–345. https://doi.org/10.1016/j.neulet.2017.10.060
Vallelunga A, Pegoraro V, Pilleri M, Biundo R, De Iuliis A, Marchetti M, Facchini S, Formento Dojot P, Antonini A (2014) The MTHFR C677T polymorphism modifies age at onset in Parkinson’s disease. Neurol Sci 35(1):73–77. https://doi.org/10.1007/s10072-013-1545-z
Yuan L, Song Z, Deng X, Xiong W, Yang Z, Deng H (2016) Association of the MTHFR rs1801131 and rs1801133 variants in sporadic Parkinson’s disease patients. Neurosci Lett 616:26–31. https://doi.org/10.1016/j.neulet.2016.01.031
Zahra C, Tabone C, Camilleri G, Felice AE, Farrugia R, Bezzina Wettinger S (2016) Genetic causes of Parkinson’s disease in the Maltese: a study of selected mutations in LRRK2, MTHFR, QDPR and SPR. BMC Med Genet 17(1):65. https://doi.org/10.1186/s12881-016-0327-x
Hashida H, Goto J, Zhao N, Takahashi N, Hirai M, Kanazawa I, Sakaki Y (1998) Cloning and mapping of ZNF231, a novel brain-specific gene encoding neuronal double zinc finger protein whose expression is enhanced in a neurodegenerative disorder, multiple system atrophy (MSA). Genomics 54(1):50–58. https://doi.org/10.1006/geno.1998.5516
Acknowledgements
We thank all the patients who participated in this study.
Funding
This study was funded by the National Natural Science Foundation of China [grant numbers 81601010, 81701039]; Young Excellent Talents in Tongji University (22120180604), Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai [Grant No. PWZxq2017–08] and the Outstanding Leaders Training Program of Pudong new area health system of Shanghai [Grant No. PWRl2018–01].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethic committee of shanghai East hospital affiliated to Tongji University and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, B., Cui, C., Yu, H. et al. Association between ZNF184 and symptoms of Parkinson’s disease in southern Chinese. Neurol Sci 41, 2121–2126 (2020). https://doi.org/10.1007/s10072-020-04309-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04309-5